Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+52.7%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+52.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$304.64M+305.1%
2023$75.19M+12.4%
2022$66.92M-21.7%
2021$85.49M-